Company: ARWR
Filing Date: 2025-11-25
Form Type: 10-K
Source: 0000879407-25-000029
Chunk: 15

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-11-25
Form: 10-K
Item: Item 8
Chunk 15
---
.20Common Stock Purchase Agreement between the Company and Amgen Inc., dated September 28, 2016Amendment No. 1 to the Registration Statement on Form S-3, as Exhibit 10.1)November 25, 201610.21†License Agreement by and between Arrowhead Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc., dated October 3, 2018Quarterly Report on Form 10-Q, as Exhibit 10.1February 7, 201910.22†Amendment No. 1 to License Agreement by and between Arrowhead Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc., dated December 18, 2018Annual Report on Form 10-K, as Exhibit 10.19November 25, 201910.23†Amendment No. 2 to License Agreement by and between Arrowhead Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc., dated February 4, 2019Annual Report on Form 10-K, as Exhibit 10.20November 25, 201910.24†Amended and Restated License Agreement by and between Arrowhead Pharmaceuticals, Inc. and GlaxoSmithKline Intellectual Property (No. 3) Limited, dated December 11, 2023Quarterly Report on Form 10-Q, as Exhibit 10.1August 8, 202410.25Stock Purchase Agreement by and between Johnson & Johnson Innovation-JJDC, Inc. and Arrowhead Pharmaceuticals, Inc., dated October 3, 2018Quarterly Report on Form 10-Q, as Exhibit 10.3February 7, 201910.26†Exclusive License and Co-Funding Agreement by and between Arrowhead Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc., dated October 7, 2020†Quarterly Report on Form 10-Q, as Exhibit 10.1February 4, 202110.27First Amendment to Exclusive License and Co-Funding Agreement by and between Arrowhead Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. dated March 15, 2022Quarterly Report on Form 10-Q, as Exhibit 10.1May 10, 202210.28†Collaboration and License Agreement by and between Arrowhead Pharmaceuticals, Inc. and Horizon Therapeutics Ireland DAC, dated June 18, 2021Quarterly Report on Form 10-Q, as Exhibit 10.4